Apple AirPods Pro 2 vs Resound Vivia 9 60S microRIE

The Apple AirPods Pro 2 is a budget-priced OTC hearing aid that earns an A grade with a SoundScore of 4.1/5 in our lab testing, placing it in the top 26% of OTC hearing aids tested. At $249, it represents one of the more affordable options in the category while delivering strong overall performance. In our testing, the AirPods Pro 2 shows particular strength in speech clarity for quiet environments, scoring 4.2/5—a strong result that sits 1.38 points above the category average. Music streaming is where this device truly excels, earning 4.4/5 and outperforming the category average by a substantial 2.48 points. Feedback handling is excellent at 5.0/5, meaning users should experience virtually no whistling issues. The device does have limitations. Own-voice comfort scores 1.9/5, which is low in absolute terms and 0.61 points below the category average—users may notice their own voice sounds different or boomy. Speech in noise performance is above average for the category at 2.3/5 (+0.77 points), but this remains a mixed result in absolute terms, suggesting challenging listening environments will still be difficult. The AirPods Pro 2 is best suited for consumers already in the Apple ecosystem who want hearing support primarily in quieter settings and value excellent music and media streaming. Those frequently in noisy environments or sensitive to own-voice changes may want to consider alternatives.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.